Sun Pharma launches dry eye treatment with NCELL tech in Canada
CEQUA’s NCELL technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration
Source: biospectrumindia.com
Stay updated with breaking news from W Bruce Jackson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CEQUA’s NCELL technology improves the bioavailability and physicochemical stability of cyclosporine to increase ocular tissue penetration